1949. Activity of Aztreonam-Avibactam against Enterobacterales Resistant to Recently Approved Beta-Lactamase Inhibitor Combinations Collected Worldwide (ex-US; 2020–2022)

BACKGROUND: Aztreonam-avibactam (ATM-AVI) is under clinical development. Aztreonam is a monobactam stable to hydrolysis by metallo-β-lactamases (MBLs). ATM-AVI has shown activity against MBL-producing, carbapenem-resistant Enterobacterales (CRE) that are resistant to recently approved β-lactamase in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sader, Helio S, Castanheira, Mariana, Duncan, Leonard R, Kimbrough, John H, Carvalhaes, Cecilia G, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677052/
http://dx.doi.org/10.1093/ofid/ofad500.103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677052/
http://dx.doi.org/10.1093/ofid/ofad500.103

Ejemplares similares